Tolerability and safety of anti-fibrotic agents for idiopathic pulmonary fibrosis in real world

被引：0
|
作者：
Sugimoto, Chikatoshi
Inoue, Yoshikazu
Arai, Toru
Kasai, Takehiko
Akira, Masanori
Hayashi, Seiji
Tachibana, Kazunobu
Sasaki, Yumiko
Takeuchi, Naoko
Minomo, Syojiro
Ikegami, Naoya
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.PA4878
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4878
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Bonovolias, Ioannis
    Sun, Qingzhu
    Tamm, Michael
    Lambers, Christopher
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [32] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin E.
    Zhong, Jun
    Papakonstantinou, Eleni
    Karakiulakis, George
    Tamm, Michael
    Seidel, Petra
    Sun, Qingzhu
    Mandal, Jyotshna
    Lardinois, Didier
    Lambers, Christopher
    Roth, Michael
    RESPIRATORY RESEARCH, 2014, 15
  • [33] Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis
    Ishii, Daisuke
    Kawasaki, Takeshi
    Sato, Hironori
    Tatsumi, Koichiro
    Imamoto, Takuro
    Yoshioka, Keiichiro
    Abe, Mitsuhiro
    Hasegawa, Yoshinori
    Ohara, Osamu
    Suzuki, Takuji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [34] Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Katrin E Hostettler
    Jun Zhong
    Eleni Papakonstantinou
    George Karakiulakis
    Michael Tamm
    Petra Seidel
    Qingzhu Sun
    Jyotshna Mandal
    Didier Lardinois
    Christopher Lambers
    Michael Roth
    Respiratory Research, 15
  • [35] Characteristics Of Patients With Idiopathic Pulmonary Fibrosis (ipf) Receiving Approved Anti-Fibrotic Therapies In The Us
    Gamerman, V.
    Salisbury, M.
    Culver, D.
    Leonard, T.
    Neely, M. L.
    Yow, E.
    Conoscenti, C. S.
    Palmer, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [36] Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing
    Burgess, Andrew
    Goon, Ken
    Brannan, John D.
    Attia, John
    Palazzi, Kerrin
    Oldmeadow, Christopher
    Corte, Tamera J.
    Glaspole, Ian
    Goh, Nicole
    Keir, Gregory
    Allan, Heather
    Chapman, Sally
    Cooper, Wendy
    Ellis, Samantha
    Hopkins, Peter
    Moodley, Yuben
    Reynolds, Paul
    Zappala, Chris
    Macansh, Sacha
    Grainge, Christopher
    RESPIROLOGY, 2019, 24 (10) : 988 - 995
  • [37] A prosprective study on the safety, tolerability and efficacy of pirfinidone in the treatment of idiopathic pulmonary fibrosis and fibrotic NSIP
    Balakrishnan, Ratna
    Madas, Sapna
    Brasier, Bill
    Rajan, Sujeet
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [38] Anti-fibrotic effect of FGF21 in pulmonary fibrosis
    Ghanem, Mada
    Archer, Gabrielle
    Justet, Aurelien
    Hachem, Mouna
    Boghanim, Tiara
    Vadel, Aurelie
    Pote, Nicolas
    Cazes, Aurelie
    Mordant, Pierre
    Castier, Yves
    Mal, Herve
    Jaillet, Madeleine
    Mailleux, Arnaud
    Crestani, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments
    Sara De Biasi
    Stefania Cerri
    Elena Bianchini
    Lara Gibellini
    Elisa Persiani
    Gloria Montanari
    Fabrizio Luppi
    Cristiano Matteo Carbonelli
    Luigi Zucchi
    Marialuisa Bocchino
    Alessandro Sanduzzi Zamparelli
    Carlo Vancheri
    Giacomo Sgalla
    Luca Richeldi
    Andrea Cossarizza
    BMC Medicine, 13
  • [40] A retrospective study of the tolerability of nintedanib for severe idiopathic pulmonary fibrosis in the real world
    Nakamura, Masayuki
    Okamoto, Masaki
    Fujimoto, Kiminori
    Ebata, Tomohiro
    Tominaga, Masaki
    Nouno, Takashi
    Zaizen, Yoshiaki
    Kaieda, Shinjiro
    Tsuda, Tohru
    Kawayama, Tomotaka
    Hoshino, Tomoaki
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (12)
12345